Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system

There are several reviews on NO and hydrogen sulfide (H2S) and their role in vascular diseases in the current relevant literature. The aim of this review is to discuss, within the limits of present knowledge, the interconnection between these two gasotransmitters in vascular function. In particular, the review focuses on the role played by the balance between the NO and H2S pathways in either physiological or pathological conditions. The distinction between physiology and pathology has been made in order to dissect the molecular basis of this crosstalk, highlighting how and if this balance varies, depending upon the vascular status. Perspectives and possible novel therapeutic approaches are also discussed.

[1]  K. Eto,et al.  A Novel Enhancing Mechanism for Hydrogen Sulfide-producing Activity of Cystathionine β-Synthase* , 2002, The Journal of Biological Chemistry.

[2]  J. Snipes,et al.  Potassium Channel Dysfunction in Cerebral Arteries of Insulin-Resistant Rats Is Mediated by Reactive Oxygen Species , 2004, Stroke.

[3]  Chen Yu,et al.  H2S Inhibits Hyperglycemia-Induced Intrarenal Renin-Angiotensin System Activation via Attenuation of Reactive Oxygen Species Generation , 2013, PloS one.

[4]  A. Papapetropoulos,et al.  Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer , 2013, Proceedings of the National Academy of Sciences.

[5]  J. Stamler,et al.  S-Nitrosylation of Cardiac Ion Channels , 2009, Journal of cardiovascular pharmacology.

[6]  Long-Xin Gui,et al.  Alterations in Caveolin-1 Expression and Receptor-Operated Ca2+ Entry in the Aortas of Rats with Pulmonary Hypertension , 2016, Cellular Physiology and Biochemistry.

[7]  N. Cui,et al.  Oxidative Stress Inhibits Vascular KATP Channels by S-Glutathionylation* , 2010, The Journal of Biological Chemistry.

[8]  R. D. Rudic,et al.  In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation , 2000, Nature Medicine.

[9]  S. Snyder,et al.  S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding , 2005, Nature Cell Biology.

[10]  R. Mrowka,et al.  Enhanced blood pressure variability in eNOS knockout mice. , 1999, Hypertension.

[11]  G. FitzGerald,et al.  Reduced Nitric Oxide Causes Age-Associated Impairment of Circadian Rhythmicity , 2008, Circulation research.

[12]  C. Triggle,et al.  Endothelial Cell Dysfunction and the Vascular Complications Associated with Type 2 Diabetes: Assessing the Health of the Endothelium , 2005, Vascular health and risk management.

[13]  Sihai Zhao,et al.  Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  Linda Partridge,et al.  Extending Healthy Life Span—From Yeast to Humans , 2010, Science.

[15]  J. Stamler,et al.  Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function , 2012, Proceedings of the National Academy of Sciences.

[16]  F. Murad,et al.  Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung. , 1978, The Journal of biological chemistry.

[17]  E. Johns,et al.  Exogenous Hydrogen Sulfide (H2S) Reduces Blood Pressure and Prevents the Progression of Diabetic Nephropathy in Spontaneously Hypertensive Rats , 2012, Renal failure.

[18]  K. Sakamoto,et al.  The pivotal role of eNOS uncoupling in vascular endothelial dysfunction in patients with heart failure with preserved ejection fraction. , 2015, International journal of cardiology.

[19]  F. Esposito,et al.  Vascular effects of linagliptin in non‐obese diabetic mice are glucose‐independent and involve positive modulation of the endothelial nitric oxide synthase (eNOS)/caveolin‐1 (CAV‐1) pathway , 2016, Diabetes, obesity & metabolism.

[20]  Joanna L. Sharman,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands , 2015, Nucleic Acids Res..

[21]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[22]  A. Papapetropoulos,et al.  Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A. , 2013, Biochemical pharmacology.

[23]  F. Santilli,et al.  Oxidative stress in chronic vascular disease: From prediction to prevention. , 2015, Vascular pharmacology.

[24]  A. Papapetropoulos,et al.  Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation , 2012, Proceedings of the National Academy of Sciences.

[25]  N. Matsuki,et al.  The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. , 1997, Biochemical and biophysical research communications.

[26]  M. Crabtree,et al.  Altered Plasma Versus Vascular Biopterins in Human Atherosclerosis Reveal Relationships Between Endothelial Nitric Oxide Synthase Coupling, Endothelial Function, and Inflammation , 2007, Circulation.

[27]  D. Lefer,et al.  Zofenopril Protects Against Myocardial Ischemia–Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability , 2016, Journal of the American Heart Association.

[28]  N. Bryan,et al.  Dietary nitrite restores NO homeostasis and is cardioprotective in endothelial nitric oxide synthase-deficient mice. , 2008, Free radical biology & medicine.

[29]  J. Sowers,et al.  Caveolin-1 in Cardiovascular Disease: A Double-Edged Sword , 2015, Diabetes.

[30]  Christopher Southan,et al.  The Concise Guide to PHARMACOLOGY 2015/16: Enzymes , 2015, British journal of pharmacology.

[31]  J. Terao,et al.  Effect of quercetin and its metabolite on caveolin-1 expression induced by oxidized LDL and lysophosphatidylcholine in endothelial cells , 2016, Journal of clinical biochemistry and nutrition.

[32]  Rui Wang.  Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. , 2012, Physiological reviews.

[33]  J. Wallace,et al.  Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  J. Stamler,et al.  Nascent nitrosylases , 2010, Nature Cell Biology.

[35]  N. Nagahara,et al.  Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. , 2009, Journal of biochemistry.

[36]  G. Cirino,et al.  Biosynthesis of H2S is impaired in non‐obese diabetic (NOD) mice , 2008, British journal of pharmacology.

[37]  J. Stamler,et al.  Protein S-nitrosylation in health and disease: a current perspective. , 2009, Trends in molecular medicine.

[38]  J. Wallace,et al.  Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter , 2015, Nature Reviews Drug Discovery.

[39]  S. Snyder,et al.  H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase , 2008, Science.

[40]  S. Cadenas,et al.  Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. , 2011, Free radical biology & medicine.

[41]  R. Word,et al.  Activation properties of myosin light chain kinase during contraction/relaxation cycles of tonic and phasic smooth muscles. , 1994, The Journal of biological chemistry.

[42]  A. Papapetropoulos,et al.  Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. , 2014, Cardiovascular research.

[43]  M. Insko,et al.  Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide , 2009, British journal of pharmacology.

[44]  M. Smith-Wheelock,et al.  Methionine‐deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF‐I and insulin levels, and increases hepatocyte MIF levels and stress resistance , 2005, Aging cell.

[45]  Jason G. Harrison,et al.  Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. , 2012, Chemical research in toxicology.

[46]  N. Vaziri,et al.  Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[47]  G. Savoia,et al.  Cystathionine β-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia. , 2016, Clinical science.

[48]  J. Stamler,et al.  S-nitrosylation in health and disease. , 2003, Trends in molecular medicine.

[49]  P. Kuppusamy,et al.  Oxidative stress in cardiovascular disease. , 2009, Indian journal of biochemistry & biophysics.

[50]  S. Snyder,et al.  H2S Signals Through Protein S-Sulfhydration , 2009, Science Signaling.

[51]  P. Tsao,et al.  Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM , 1997, Diabetes Care.

[52]  J. Bian,et al.  Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System , 2015, Oxidative medicine and cellular longevity.

[53]  J. Beavo,et al.  Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. , 2007, Annual review of biochemistry.

[54]  M. Sampson,et al.  Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. , 1996, Journal of the American College of Cardiology.

[55]  R. Feil,et al.  cGMP-Dependent Protein Kinase Contributes to Hydrogen Sulfide-Stimulated Vasorelaxation , 2012, PloS one.

[56]  P. Moore,et al.  Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis , 2015, Oxidative medicine and cellular longevity.

[57]  M. A. Lasunción,et al.  Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. , 2009, Cell metabolism.

[58]  M. Insko,et al.  Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. , 2010, British journal of clinical pharmacology.

[59]  S. Jha,et al.  Genetic and Pharmacologic Hydrogen Sulfide Therapy Attenuates Ischemia-Induced Heart Failure in Mice , 2010, Circulation.

[60]  Y. Abed,et al.  Atherosclerotic cardiovascular disease: a review of initiators and protective factors , 2016, Inflammopharmacology.

[61]  B. Gaston,et al.  Compartmentalized Connexin 43 S-Nitrosylation/Denitrosylation Regulates Heterocellular Communication in the Vessel Wall , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[62]  C. Roussos,et al.  Hydrogen Sulfide Is an Endogenous Inhibitor of Phosphodiesterase Activity , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[63]  K. Abe,et al.  The possible role of hydrogen sulfide as an endogenous neuromodulator , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[64]  M. Lisanti,et al.  Endothelial caveolin-1 plays a major role in the development of atherosclerosis , 2014, Cell and Tissue Research.

[65]  Kan Chen,et al.  Association of hydrogen sulfide with alterations of monocyte chemokine receptors, CCR2 and CX3CR1 in patients with coronary artery disease , 2015, Inflammation Research.

[66]  J. Stull,et al.  Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo. , 2008, American journal of physiology. Cell physiology.

[67]  L. Morbidelli,et al.  H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall. , 2016, Pharmacological research.

[68]  Rui Wang,et al.  The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener , 2001 .

[69]  G. Garcı́a-Cardeña,et al.  Reconstitution of an Endothelial Nitric-oxide Synthase (eNOS), hsp90, and Caveolin-1 Complex in Vitro , 2000, The Journal of Biological Chemistry.

[70]  Baoping Yu,et al.  Enhanced Expression of Cystathionine β-Synthase and Cystathionine γ-Lyase During Acute Cholecystitis-Induced Gallbladder Inflammation , 2013, PloS one.

[71]  J. Wallace,et al.  The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. , 2006, Gastroenterology.

[72]  J. Stamler,et al.  Protein denitrosylation: enzymatic mechanisms and cellular functions , 2009, Nature Reviews Molecular Cell Biology.

[73]  W. Armstead,et al.  Differential role of PTK and ERK MAPK in superoxide impairment of K(ATP) and K(Ca) channel cerebrovasodilation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[74]  A. Nicolosi,et al.  Diabetes Mellitus Impairs Vasodilation to Hypoxia in Human Coronary Arterioles: Reduced Activity of ATP-Sensitive Potassium Channels , 2003, Circulation research.

[75]  K. Olson.  A practical look at the chemistry and biology of hydrogen sulfide. , 2012, Antioxidants & redox signaling.

[76]  H. E. Marshall,et al.  Thioredoxin-interacting Protein (Txnip) Is a Feedback Regulator of S-Nitrosylation , 2009, The Journal of Biological Chemistry.

[77]  S. Gross,et al.  S-sulfhydration/desulfhydration and S-nitrosylation/denitrosylation: a common paradigm for gasotransmitter signaling by H2S and NO. , 2013, Methods.

[78]  J. Stamler,et al.  Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease , 2012, Journal of Molecular Medicine.

[79]  D. Kass,et al.  Abstract 3379: cGMP Specific Phosphodiesterase Type 5A Activity is Regulated by S-nitrosylation at Cys 181 , 2008 .

[80]  Rui Wang.  Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  J. Stamler,et al.  S-nitrosoglutathione reductase: an important regulator in human asthma. , 2009, American journal of respiratory and critical care medicine.

[82]  J. Stamler,et al.  Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn , 2002, The Lancet.

[83]  T. Mazzone,et al.  Apolipoprotein E Enhances Endothelial-NO Production by Modulating Caveolin 1 Interaction With Endothelial NO Synthase , 2012, Hypertension.

[84]  J. Stamler,et al.  S-Nitrosylation in Cardiovascular Signaling , 2010, Circulation research.

[85]  C. Szabó.  Hydrogen sulphide and its therapeutic potential , 2007, Nature Reviews Drug Discovery.

[86]  Maria Laura Luchetta,et al.  Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients. , 2007, American journal of hypertension.

[87]  R. Marthan,et al.  Caveolae are involved in mechanotransduction during pulmonary hypertension. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[88]  V. Gladyshev,et al.  Endogenous Hydrogen Sulfide Production Is Essential for Dietary Restriction Benefits , 2015, Cell.

[89]  Yingzi Zhao,et al.  Vascular nitric oxide: Beyond eNOS. , 2015, Journal of pharmacological sciences.

[90]  B. Halliwell,et al.  The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’? , 2004, Journal of neurochemistry.

[91]  W. Sessa,et al.  Diabetic Mouse Angiopathy Is Linked to Progressive Sympathetic Receptor Deletion Coupled to an Enhanced Caveolin-1 Expression , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[92]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[93]  N. Nagahara,et al.  Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis , 1998, Histochemistry and Cell Biology.

[94]  Hongzhu Li,et al.  Decreased Endogenous Production of Hydrogen Sulfide Accelerates Atherosclerosis , 2013, Circulation.

[95]  J. Aschner,et al.  Tetrahydrobiopterin oral therapy recouples eNOS and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[96]  Y. Huang,et al.  Endothelial‐specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions , 2007, The American journal of pathology.

[97]  L. Ignarro,et al.  Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. , 1988, The Journal of pharmacology and experimental therapeutics.

[98]  Stephen Hancocks,et al.  Two's company, three's a crowd , 2004, British Dental Journal.

[99]  M. Suematsu,et al.  Cystathionine γ-Lyase-deficient Mice Require Dietary Cysteine to Protect against Acute Lethal Myopathy and Oxidative Injury* , 2010, The Journal of Biological Chemistry.

[100]  J. Kraus,et al.  Cystathionine β-Synthase: Structure, Function, Regulation, and Location of Homocystinuria-causing Mutations* , 2004, Journal of Biological Chemistry.